StockData
DMAANasdaqBlank ChecksFiscal year ends December 31Also trades as DMAAR, DMAAU

Drugs Made In America Acquisition Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.87+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

SEC filings

23 of Drugs Made In America Acquisition's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report8-KOct 13, 2026Oct 21, 2026SEC EDGAR
Current report8-KSep 8, 2026Sep 14, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 14, 2026SEC EDGAR
Current report8-KJul 14, 2026Jul 20, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 14, 2026SEC EDGAR
Current report8-KApr 29, 2026May 5, 2026SEC EDGAR
Current report8-KApr 27, 2026May 1, 2026SEC EDGAR
Current report8-KApr 22, 2026Apr 28, 2026SEC EDGAR
Annual report10-KDec 31, 2025Apr 15, 2026SEC EDGAR
Proxy statementDEF 14AApr 27, 2026Apr 14, 2026SEC EDGAR
Current report8-KApr 7, 2026Apr 8, 2026SEC EDGAR
Current report8-KMar 23, 2026Mar 27, 2026SEC EDGAR
Current report8-KMar 6, 2026Mar 6, 2026SEC EDGAR
Current report8-KFeb 28, 2026Mar 6, 2026SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 18, 2025SEC EDGAR
Current report8-KOct 8, 2025Nov 18, 2025SEC EDGAR
Quarterly report10-QJun 30, 2025Aug 14, 2025SEC EDGAR
Quarterly report10-QMar 31, 2025May 20, 2025SEC EDGAR
Annual report10-KDec 31, 2024Mar 31, 2025SEC EDGAR
Current report8-KFeb 18, 2025Feb 25, 2025SEC EDGAR
Current report8-KFeb 20, 2025Feb 24, 2025SEC EDGAR
Current report8-KJan 29, 2025Feb 4, 2025SEC EDGAR
Current report8-KJan 27, 2025Jan 30, 2025SEC EDGAR